Atlas Trials

Study of Sintlimab Maintenance Therapy in Patients With Extensive Small Cell Lung Cancer

Clinical trial NCT03983759 · UNKNOWN

Trial details

NCT number
NCT03983759
Sponsor
Henan Cancer Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Small Cell Lung CancerExtensive DiseaseAdoptive Cellular ImmunotherapyChemotherapyMaintenance
Start date
2019-06-20
Primary completion
2021-05-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.